Skip to main content
NEOG
NASDAQ Life Sciences

Neogen's Chief Legal Officer Departs Amid Ongoing Legal Challenges

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$8.8
Mkt Cap
$1.892B
52W Low
$3.87
52W High
$11.425
52W Position info
127% above low
Off High info
23% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

NEOG has more than doubled off its 52-week low of $3.87.

Summary

Neogen Corporation announced the departure of its Chief Legal and Administrative Officer, Amy Rocklin, effective March 31, 2026, raising questions given the company's existing legal and control issues.


Key Events · Executive and Board Changes · NEOG

  • Chief Legal Officer Resigns

    Amy Rocklin, Neogen's Chief Legal and Administrative Officer, will depart the company effective March 31, 2026.

  • Leadership Change Amidst Legal Issues

    The departure comes as Neogen faces ongoing shareholder lawsuits related to its 3M acquisition and previously disclosed material weaknesses in internal controls.


Analysis · NEOG · Life Sciences

The departure of Neogen's Chief Legal and Administrative Officer, Amy Rocklin, is a notable event, especially in light of the company's previously disclosed material weaknesses in internal controls and ongoing shareholder lawsuits related to its 3M acquisition. The Chief Legal Officer plays a critical role in managing legal risks and ensuring compliance. This change in leadership could introduce uncertainty regarding the company's strategy for addressing these significant challenges. Investors should monitor future disclosures for details on a replacement and any impact on the company's legal and administrative functions.

How filings like this one have moved

In the 30 days to Oct 1, 2026, 30.2% of the 1644 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, NEOG was trading at $8.80 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.9B. The 52-week trading range was $3.87 to $11.43. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NEOG - Latest Insights

NEOG
Sep 29, 2026, 11:12 AM EDT
Source: Seeking Alpha
Importance Score:
8
Price at Filing: $13.46
Real-time Price: $12.80 info
Change: -$0.660 (-5%) info
Market Cap: $2.792B info
NEOG
Jul 30, 2026, 4:04 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $11.46
Real-time Price: $12.80 info
Change: +$1.34 (+12%) info
Market Cap: $2.792B info
NEOG
Jul 30, 2026, 7:01 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $9.57
Real-time Price: $12.80 info
Change: +$3.23 (+34%) info
Market Cap: $2.792B info
NEOG
Apr 09, 2026, 4:03 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $10.04
Real-time Price: $12.80 info
Change: +$2.77 (+28%) info
Market Cap: $2.792B info
NEOG
Apr 09, 2026, 7:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $9.47
Real-time Price: $12.80 info
Change: +$3.33 (+35%) info
Market Cap: $2.792B info